for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Gerresheimer AG

GXIG.DE

Latest Trade

63.65EUR

Change

-0.70(-1.09%)

Volume

44,789

Today's Range

62.90

 - 

64.25

52 Week Range

51.10

 - 

74.80

As of on the XETRA ∙ Minimum 15 minute delay

Pricing

Previous Close
64.35
Open
63.85
Volume
44,789
3M AVG Volume
2.09
Today's High
64.25
Today's Low
62.90
52 Week High
74.80
52 Week Low
51.10
Shares Out (MIL)
31.40
Market Cap (MIL)
2,020.59
Forward P/E
13.66
Dividend (Yield %)
1.71

Next Event

Gerresheimer AG Roadshow- London

Latest Developments

More

Gerresheimer Confirms Revenue Guidance After Q2 Results

Gerresheimer Names Bernd Metzner CFO

Gerresheimer Confirms Revenue Guidance After Q1

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Gerresheimer AG

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.

Industry

Medical Equipment & Supplies

Contact Info

Klaus-Bungert-Strasse 4

+49.211.618100

https://www.gerresheimer.com/

Executive Leadership

Axel Herberg

Independent Chairman of the Supervisory Board

Dietmar Siemssen

Chairman of the Management Board, Chief Executive Officer

Francesco Grioli

Deputy Chairman of the Supervisory Board

Bernd Metzner

Chief Financial Officer, Member of the Management Board

Lukas Burkhardt

Member of the Management Board, responsible for the Primary Packaging Glass Division

Key Stats

2.75 mean rating - 16 analysts
Sell
Hold
Buy
Revenue (MM, EUR)

2016

1.4K

2017

1.3K

2018

1.4K

2019(E)

1.4K
EPS (EUR)

2016

4.220

2017

4.060

2018

5.670

2019(E)

4.709
Price To Earnings (TTM)
25.60
Price To Sales (TTM)
1.43
Price To Book (MRQ)
1.96
Price To Cash Flow (TTM)
8.85
Total Debt To Equity (MRQ)
103.69
LT Debt To Equity (MRQ)
65.74
Return on Investment (TTM)
4.30
Return on Equity (TTM)
3.24

Latest News

Latest News

Gerresheimer buys Swiss firm Sensile Medical for up to 350 mln euros

* Maximum price of 350 mln euros depends on meeting milestones

BRIEF-Gerresheimer Posts Rise in Q4 Profit, Hikes Dividend​

* FOURTH-QUARTER REVENUES UP 4.7%, WITH ORGANIC GROWTH OF 6.7%.

BRIEF-Christian Fischer Resigns As CEO Of Gerresheimer AG

* GERRESHEIMER AG: DR. CHRISTIAN FISCHER RESIGNS AS CEO OF GERRESHEIMER AG

BRIEF-Gerresheimer sees significant boost from U.S. tax reform​

* EXPECTS SIGNIFICANT POSITIVE EFFECTS FROM US TAX REFORM IN 2018

Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG, as its new chief executive, the company said on Monday.

Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

Generic drugmaker Perrigo Company Plc appointed former Gerresheimer AG Chief Executive Uwe Rohrhoff as its new president and CEO, the company said on Monday.

BRIEF-Gerresheimer says acquisitions remain part of strategy

Gerresheimer AG management on conference call:

UPDATE 1-Gerresheimer's targets in jeopardy over U.S. healthcare confusion

* Says delivering Q4 orders is a challenge (Adds more details on outlook, shares)

BRIEF-Corning and Gerresheimer collaborate to deliver new Corning valor(tm) glass to the pharmaceutical packaging market

* Corning and Gerresheimer collaborate to deliver new corning valor(tm) glass to the pharmaceutical packaging market

Gerresheimer says has solid orders for H2 in U.S. glass

Gerresheimer already has firm orders for 80 percent of what it expects to make in second-half sales in its U.S. glass business, Chief Executive Uwe Roehrhoff told reporters on Thursday, reiterating his optimism about the end of the year.

UPDATE 1-Germany's Gerresheimer trims forecast, eyes H2 pick-up

* Shares at 19-month lows, down 2.7 percent (Adds details on forecast, shares)

Germany's Gerresheimer eyes pick-up in second half

German drugs-packaging maker Gerresheimer said it expected business to pick up in the second half of this year after a second quarter that showed further evidence of caution by U.S. customers due to uncertainty over healthcare policy.

Gerresheimer sees U.S. uncertainty continuing this quarter

German drugs-packaging maker Gerresheimer expects confusion over U.S. healthcare policy to continue to be a drag on revenues this quarter, with a normalisation coming in the second half of the year, its chief executive said on Thursday.

UPDATE 1-U.S. healthcare confusion hits packaging firm Gerresheimer

* Shares drop almost 6 percent (Adds details on outlook, shares, analyst comment)

Gerresheimer says customers holding off orders amid U.S. uncertainty

German drugs-packaging firm Gerresheimer on Thursday said its major pharmaceutical customers had been more cautious in placing orders due to uncertainty over the new U.S. administration's policies.

Gerresheimer appoints BASF's Christian Fischer as new CEO

German drugs-packaging firm Gerresheimer appointed Christian Fischer, currently president of performance chemicals at BASF, as its new chief executive.

BRIEF-Gerresheimer says Christian Fischer to be appointed CEO

* Christian Fischer to join management board on August 1, 2017 before taking over as CEO on September 1, 2017 Source text - http://bit.ly/2mhGtxQ

BRIEF-Gerresheimer CEO says acquisitions for 500 mln euros doable

* Says takeovers in range of 500 million eur certainly doable

BRIEF-Gerresheimer targets around 23 pct adj 2018 Ebitda margin

* Says expects around 1.43 billion eur sales in 2017, around 320 million eur adjusted Ebitda

UPDATE 1-Gerresheimer Q3 profit beats consensus on strong inhaler sales

German drugs packaging firm Gerresheimer reports a bigger-than-expected rise in third-quarter core profit as strong sales of asthma inhalers help bolster earnings at its Plastic & Devices division.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up